|1.||Bolton, J L: 2 articles (06/2001 - 05/2000)|
|2.||van Breemen, R B: 2 articles (06/2001 - 05/2000)|
|3.||Hua, Y: 2 articles (06/2001 - 05/2000)|
|4.||Zhang, F: 2 articles (06/2001 - 05/2000)|
|5.||Cuendet, Muriel: 1 article (12/2004)|
|6.||Chang, Minsun: 1 article (12/2004)|
|7.||Li, Yan: 1 article (12/2004)|
|8.||Bolton, Judy L: 1 article (12/2004)|
|9.||Yao, Jiaqin: 1 article (12/2004)|
|10.||Yao, D: 1 article (06/2001)|
|1.||Breast Neoplasms (Breast Cancer)
05/01/2000 - "A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines."
06/01/2001 - "Finally, preliminary studies conducted with the human breast tumor S-30 cell lines demonstrated that the catechol metabolites of 8,9-dehydroestrone were much less toxic than 4-hydroxyequilenin (20-40-fold). "
12/30/2004 - "4-Hydroxyequilenin (4-OHEN), a major catechol metabolite of equine estrogens present in Premarin, an estrogen replacement formulation, has been shown to induce apoptosis and DNA damage in human breast cancer cells. "
02/01/1999 - "Finally, preliminary studies conducted with the human breast tumor cell line MCF-7 demonstrated that the cytotoxic effects of the catechol estrogens from estrone, equilin, and 2-hydroxyequilenin were similar, whereas 4-hydroxyequilenin was a much more potent cytotoxin ( approximately 30-fold). "
|2.||Melanoma (Melanoma, Malignant)
|5.||3- hydroxy- 1,3,5(10),8,9- estratetraen- 17- one
|8.||Conjugated (USP) Estrogens (Premarin)
|1.||Estrogen Replacement Therapy